Bu-Fei Yi-Shen Granules Reduce Acute Exacerbations in Patients with GOLD 3-4 COPD: A Randomized Controlled Trial.

Purpose: Chronic obstructive pulmonary disease (COPD) is a disease characterized by frequent acute exacerbations (AEs), especially in severe and very severe cases. We aimed to evaluate the efficacy and safety of Bu-fei Yi-shen granules (BYGs) for COPD. Patients and Methods: We conducted a multicenter, randomized, double-blinded, placebo-controlled trial of 348 COPD patients with GOLD 3-4 COPD. The patients were randomly assigned into experimental or control groups in a 1:1 ratio. Patients in the experimental group were prescribed BYG, while those in the control group were administered a placebo, orally, twice daily, with 5 days on and 2 days off per week for 52 weeks. The outcomes included AEs, pulmonary function, clinical signs and symptoms, dyspnea scores (mMRC), quality of life scores, and a 6-minute walk test (6MWT). Results: A total of 280 patients completed the trial, including 135 patients in the experimental group and 145 in the control group. Compared to the control group, significant differences were observed in frequencies of AEs (mean difference: -0.35; 95% CI: -0.61, -0.10; P = 0.006) and AE-related hospitalizations (-0.18; 95% CI: -0.36, -0.01; P = 0.04), 6MWD (40.93 m; 95% CI: 32.03, 49.83; P < 0.001), mMRC (-0.57; 95% CI: -0.76, -0.37; P < 0.001), total symptoms (-2.18; 95% CI: -2.84, -1.53; P < 0.001), SF-36 (11.60; 95% CI: 8.23, 14.97; P < 0.001), and mCOPD-PRO (-0.45; 95% CI: -0.57, -0.33; P < 0.001) after treatment. However, there were no significant differences in mortality, pulmonary function, and mESQ-PRO scores (P > 0.05). No obvious adverse events were observed. Conclusion: BYG, as compared to a placebo, could significantly reduce the frequencies of AEs and AE-related hospitalizations for GOLD 3-4 COPD patients. Clinical symptoms, treatment satisfaction, quality of life, and exercise capacity improved. There was no significant improvement in mortality and pulmonary function.

Three Si-substituted polyoxovanadates as efficient catalysts for Knoevenagel condensation and selective oxidation of styrene to benzaldehyde.

Three new Si-substituted polyoxovanadates (POVs), [Cd2(dien)2][Cd(dien)][Cd(Hdien)2][V15Si6O46(OH)2(H2O)]·7H2O (1), [Co(enMe)2]3[Co2(enMe)2(H2O)2][V16Si4O44(OH)2(H2O)]·6H2O (2), and [Co(teta)]4[V16Si4O42(OH)4(H2O)]·10H2O (3) (dien = diethylenetriamine; enMe = 1,2-diaminopropane; teta = triethylenetetramine) were synthesized by the hydrothermal method and characterized. Structural analysis sheds light on the fact that the {V15Si6O48}/{V16Si4O46} clusters of compounds 1-3 were formed by replacing {VO5} square pyramids in the classical {V18O42} cluster with {Si2O7} units. Compound 1 is a 2D bilayer structure formed by the [V15Si6O46(OH)2(H2O)]10- cluster and two types of bridging Cd complexes containing binuclear groups [Cd2(dien)2]4+. Compound 2 is a 3D framework constructed from the [V16Si4O44(OH)2(H2O)]10- cluster and two types of Co complex fragments including binuclear [Co2(enMe)2(H2O)2]4+. In compound 3, the [V16Si4O42(OH)4(H2O)]8- cluster is connected with bridging [Co(teta)]2+ to expand into a 2D network. Compounds 1 and 3 represent the first 2D assemblies based on a vanadosilicate cluster. 1-3 served as heterogeneous catalysts and exhibited highly efficient catalytic activities for the Knoevenagel condensation under mild ambient conditions with low catalyst loading, featuring the open Lewis base {V15Si6O48}/{V16Si4O46} sites and Lewis acid Cd2+/Co2+ sites. The conversion of benzaldehyde was up to 99.3% in 80 min at room temperature using 1 as a heterogeneous catalyst with only 0.37% catalyst loading. Moreover, compounds 1-3 as catalysts for selective oxidation of styrene to benzaldehyde exhibited excellent catalytic performance, high selectivity and could be readily recycled. Most strikingly, compound 1 showed excellent catalytic performance with 97.6% conversion of styrene and 100% selectivity of benzaldehyde in 15 min. In addition, the catalytic activity of catalyst 1 was well maintained after five cycling reactions.

Catalyst-free Synthesis of Aminomethylphenol Derivatives in Cyclopentyl Methyl Ether via Petasis Borono-Mannich Reaction.

OBJECTIVE: Aminomethylphenol molecules have wider applications in pharmaceuticals, agrochemicals, plant protection and promising functional materials. The development of an efficient and practical method to prepare this class of compound is highly desirable from both environmental and economical points of view. MATERIALS AND METHODS: In order to establish an effective synthetic method for preparing aminomethylphenol derivatives, the Petasis borono-Mannich reaction of salicylaldehyde, phenylboronic acid and 1,2,3,4- tetrahydroisoquinoline was selected as a model reaction. A variety of reaction conditions are investigated, including solvent and temperature. The generality and limitation of the established method were also evaluated. RESULTS AND DISCUSSION: It was found that model reaction can be carried out in cyclopentyl methyl ether at 80 oC under catalyst-free conditions. This protocol, with broad substrate applicability, the reaction of various arylboronic acid, secondary amine and salicylaldehyde proceeded smoothly under optimal reaction conditions to afford various aminomethylphenol derivatives in high yields. A practical, scalable, and high-yielding synthesis of aminomethylphenol derivatives was successfully accomplished. CONCLUSION: A catalyst-free practical method for the synthesis of minomethylphenol derivatives based on Petasis borono-Mannich (PBM) reaction of various arylboronic acid, secondary amine and salicylaldehyde in cyclopentyl methyl ether has been developed. The salient features of this protocol are avoidance of any additive/catalyst and toxic organic solvents, use of cyclopentyl methyl ether as the reaction medium, clean reaction profiles, easy operation, and high to excellent yield.

Moist exposed burn ointment promotes cutaneous excisional wound healing in rats involving VEGF and bFGF.

Cutaneous delayed wounds are a challenging clinical problem, and vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) exhibit key roles in wound healing. Moist exposed burn ointment (MEBO), a Chinese burn ointment with a USA patented formulation, has been reported to promote chronic ischemic and neurogenic ulcer healing in patients; however, the underlying mechanisms remain unclear. In the present study, MEBO significantly promoted the formation of granulation tissue in cutaneous excisional wounds, shortened the time of wound healing, and increased neovascularization and the number of fibroblasts. Furthermore, as well as enhancing the protein expression, MEBO application also increased the gene expression of VEGF and bFGF. The results indicate that MEBO promotes cutaneous excisional wound healing by at least partially enhancing VEGF and bFGF production, implicating the potential uses of MEBO for delayed cutaneous wound healing.